Today's picks
Top candidates from last night's scan. Scores refresh each evening; prices are live.
Some outbound links (e.g. TradingView) may be affiliate links. We may earn a commission at no extra cost to you.
Top candidates from last night's scan. Scores refresh each evening; prices are live.
Some outbound links (e.g. TradingView) may be affiliate links. We may earn a commission at no extra cost to you.
Sarepta Therapeutics, Inc.
$17.85
Weak technical setup: price above 50-day moving average, price above 200-day moving average.
Chart by TradingView
Passed
17
Failed
8
R:R
2.36:1
Confidence
high
Entry $17.85
Stop loss $16.24
Target $21.64
Quality 18/35 (4/8 passed)
Technical 15/40 (3/8 passed)
Trade setup 15/15 (4/4 passed)
Red flags 10/10 (0/6 triggered — informational, gates only)
Conviction total 53/100 — quality + technical + trade setup only. Unknown rules count as not passed.
Status: Known upside
Technical target: $21.75
Analyst target: $21.64
Effective target: $21.64
R:R 2.36:1
Entry: $17.85
Stop loss: $16.24
Effective target: $21.64
Rule-based analysis generated by Huntover. Not financial advice.
Some outbound links (e.g. TradingView) may be affiliate links. We may earn a commission at no extra cost to you.
Free cash flow is positive
Free cash flow is positive.
Debt is manageable
Debt-to-equity is 69.5% (manageable).
Market cap is not tiny / speculative
Market cap is $1.9B.
Valuation is not extreme
P/E unknown, P/S 1.0.
50-day MA above 200-day MA
50-day MA is above 200-day MA (bullish alignment).
Price not near 52-week low
21.6% above 52-week low.
Recent volume above average
Volume is 1.01x the average.
Clear entry price exists
Current price $17.85 can be used as entry reference.
Stop loss no more than 10% below entry
Suggested stop at $16.24 (9.0% below entry).
Spread / liquidity risk acceptable
Average daily volume is 2.99M.
No earnings within 7 days
Next earnings in 25 days.
Very high debt
Debt level is not extreme.
Price near 52-week low
Not near 52-week low.
Very low trading volume
Volume is not unusually low.
Recent large price drop
No recent large drop detected.
Extreme valuation
Valuation is not extreme.
Missing too much data
2 data field(s) missing.
Company is profitable
Profit margin is -6.9% (not profitable).
Revenue is growing
Revenue is declining (-34.3%).
Return on equity or capital is positive
Both ROE and ROA are not positive.
Price above 50-day moving average
Price $17.85 is below 50-day MA $19.06.
Price above 200-day moving average
Price is below 200-day MA $19.03.
Price near 52-week high
27.7% below 52-week high.
Stock is in an uptrend
Price down 12.7% over 20 days.
Breaking above recent resistance
Price below recent resistance $21.75.
EPS / earnings are growing
Earnings growth data unavailable.
Yahoo Finance did not return these inputs, so related rules may be marked unknown.
